Carmen Scheibenbogen: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Notjusttired (talk | contribs) m (fix ref error) |
Notjusttired (talk | contribs) (add hypothesis) |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
[[File:Carmen Scheibenbogen.png|200px|thumb|right|Source:Invest in ME]] | [[File:Carmen Scheibenbogen.png|200px|thumb|right|Source:Invest in ME]] | ||
Professor Doctor '''Carmen Scheibenbogen''' is an Internal Medicine physician, [[ME/CFS]] doctor and the Professor for Immunology and Deputy Chair, Institute of Medical Immunology, at the University Hospital [[Charité Berlin|Charité]] in Berlin, Germany. Her research focuses on the role of [[Epstein-Barr virus]] ([[EBV]]), particularly the characterization of [[EBV]] specific [[B cell]] and [[T cell]] response and the enhanced antibody response against [[EBV]] peptides in [[myalgic encephalomyelitis]] (ME) versus healthy controls.<ref>{{Cite web|url=http://investinme.org/cindex.shtml|title=Invest in ME Research - International ME Conferences and Colloquiums Home Page|website=investinme.org|access-date=2019-11-14}}</ref> | Professor Doctor '''Carmen Scheibenbogen''' is an Internal Medicine physician, [[ME/CFS]] doctor and the Professor for Immunology and Deputy Chair, Institute of Medical Immunology, at the University Hospital [[Charité Berlin|Charité]] in Berlin, Germany. Her research focuses on the role of [[Epstein-Barr virus]] ([[EBV]]), particularly the characterization of [[EBV]] specific [[B cell]] and [[T cell]] response and the enhanced antibody response against [[EBV]] peptides in [[myalgic encephalomyelitis]] (ME) versus healthy controls.<ref>{{Cite web|url=http://investinme.org/cindex.shtml|title=Invest in ME Research - International ME Conferences and Colloquiums Home Page|website=investinme.org|access-date=2019-11-14}}</ref> | ||
==Wirth-Scheibenbogen unifying hypothesis of ME/CFS == | |||
Between 2020 and 2021, with Prof. Dr [[Klaus Wirth]], Prof. Scheibenbogen published a set of articles describing a [[Wirth-Scheibenbogen hypothesis|detailed]] hypothesis of the pathophysiology of [[ME/CFS]].<ref name="Wirth2020a"/><ref name="Wirth2021a"/><ref name="Wirth2021b"/> | |||
==EUROMENE== | ==EUROMENE== | ||
| Line 15: | Line 18: | ||
==Notable studies== | ==Notable studies== | ||
*2014, Deficient [[EBV]]-Specific [[B cell|B-]] and [[T cell|T-Cell]] Response in Patients with | *2014, Deficient [[Epstein-Barr virus|EBV]]-Specific [[B cell|B-]] and [[T cell|T-Cell]] Response in Patients with Chronic Fatigue Syndrome<ref name="Loebel2014">{{Cite journal | ||
| last1 = Loebel | first1 = Madlen | authorlink1 = Madlen Loebel | |||
| last2 = Strohschein | first2 = Kristin | authorlink2 = | |||
| last3 = Giannini | first3 = Carolin | authorlink3 = | |||
| last4 = Koelsch | first4 = Uwe | authorlink4 = | |||
| last5 = Bauer | first5 = Sandra | authorlink5 = | |||
| last6 = Doebis | first6 = Cornelia | authorlink6 = | |||
| last7 = Thomas | first7 = Sybill | authorlink7 = | |||
*2018, The expression signature of very long non-coding [[RNA]] in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref>{{Cite journal|last=Yang|first=Chin-An|last2=Bauer|first2=Sandra|author-link2=Sandra Bauer|last3=Ho|first3=Yu-Chen|last4=Sotzny|first4=Franziska|author-link4=Franziska Sotzny|last5=Chang|first5=Jan-Gowth|last6=Scheibenbogen|first6=Carmen|author-link6=Carmen Scheibenbogen|date=2018-08-17|title=The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome|url=https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1600-x|journal=Journal of Translational Medicine|language=en|volume=16|issue= | | last8 = Unterwalder | first8 = Nadine | authorlink8 = | ||
* 2018, Prevalence and incidence of [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]] in Europe—the Euro-epiME study from the European network [[EUROMENE]]: a protocol for a systematic review<ref>{{Cite journal|last=Estévez-López|first=Fernando|author-link=Fernando Estévez-López|last2=Castro-Marrero|first2=Jesus|author-link2=Jesús Castro-Marrero|last3=Wang|first3=Xia|author-link3=Xia Wang-Steverding|last4=Bakken|first4=Inger Johanne|author-link4=Inger Johanne Bakken|last5=Ivanovs|first5=Andrejs|author-link5=Andrejs Ivanovs|last6=Nacul|first6=Luis|author-link6=Luis Nacul|last7=Sepúlveda|first7=Nuno|author-link7=Nuno Sepulveda|last8=Strand|first8=Elin B.|author-link8=Elin Strand|last9=Pheby|first9=Derek|author-link9=Derek Pheby|last10=Alegre|first10=José|author-link10=José Alegre|last11=Scheibenbogen|first11=Carmen|author-link11=Carmen Scheibenbogen|last12=Shikova|first12=Evelina|author-link12=Evelina Shikova|last13=Lorusso|first13=Lorenzo|author-link13=Lorenzo Lorusso|last14=Capelli|first14=Enrica|author-link14=Enrica Capelli|last15=Sekulic|first15=Slobodan|author-link15=Slobodan Sekulic|last16=Lacerda|first16=Eliana|author-link16=Eliana Lacerda|last17=Murovska|first17=Modra|author-link17=Modra Murovska|date=2018-09-01|title=Prevalence and incidence of myalgic encephalomyelitis/chronic fatigue syndrome in Europe—the Euro-epiME study from the European network EUROMENE: a protocol for a systematic review|url=https://bmjopen.bmj.com/content/8/9/e020817|journal=BMJ Open|language=en|volume=8|issue=9|pages=e020817|doi=10.1136/bmjopen-2017-020817|issn=2044-6055|pmc=|pmid=30181183|via=}}</ref> - [https://bmjopen.bmj.com/content/8/9/e020817 (Full text)] | | last9 = von Baehr | first9 = Volker | authorlink9 = | ||
*2018, Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)<ref>{{Cite journal|last=Rasa|first=Santa|author-link=Santa Rasa|last2=Nora-Krukle|first2=Zaiga|author-link2=Zaiga Nora-Krukle|last3=Henning|first3=Nina|author-link3=|last4=Eliassen|first4=Eva|author-link4=|last5=Shikova|first5=Evelina|author-link5=Evelina Shikova|last6=Harrer|first6=Thomas|author-link6=Thomas Harrer|last7=Scheibenbogen|first7=Carmen|author-link7=Carmen Scheibenbogen|last8=Murovska|first8=Modra|author-link8=Modra Murovska|last9=Prusty|first9=Bhupesh K.|author-link9=Bhupesh Prusty|last10=European Network on ME/CFS (EUROMENE)|first10=|author-link10=EUROMENE|date=2018-10-01|title=Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)|url=https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1644-y|journal=Journal of Translational Medicine|language=en|volume=16|issue=1|pages=|doi=10.1186/s12967-018-1644-y|issn=1479-5876|pmc=|pmid=30285773|quote=|via=}}</ref> - [https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1644-y (Full text)] | | last10 = Reinke | first10 = Petra | authorlink10 = | ||
| last11 = Knops | first11 = Michael | authorlink11 = | |||
| last12 = Hanitsch | first12 = Leif G. | authorlink12 = | |||
| last13 = Meisel | first13 = Christian | authorlink13 = | |||
| last14 = Volk | first14 = Hans-Dieter | authorlink14 = | |||
| last15 = Scheibenbogen | first15 = Carmen | authorlink15 = Carmen Scheibenbogen | |||
| title = Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome | url = https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085387 | |||
| journal = PLoS One | volume = 9 | issue = 1 | page = e85387 | |||
| date = Jan 15, 2014| pmid = | doi = 10.1371/journal.pone.0085387 }} </ref> -[https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085387 (Full Text)] | |||
*2015, Frequent [[IgG]] subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome<ref name="Guenther2015">{{Cite journal | |||
| last1 = Guenther | first1 = Sabrina | authorlink1 = | |||
| last2 = Loebel | first2 = Madlen | authorlink2 = Madlen Loebel | |||
| last3 = Mooslechner | first3 = Agnes A | authorlink3 = | |||
| last4 = Knops | first4 = Michael | authorlink4 = | |||
| last5 = Hanitsch | first5 = Leif G | authorlink5 = | |||
| last6 = Grabowski | first6 = Patricia | authorlink6 = Patricia Grabowski | |||
| last7 = Wittke | first7 = Kirsten | authorlink7 = | |||
| last8 = Meisel | first8 = Christian | authorlink8 = | |||
| last9 = Unterwalder | first9 = Nadine | authorlink9 = | |||
| last10 = Volk | first10 = Hans-Dieter | authorlink10 = | |||
| last11 = Scheibenbogen | first11 = Carmen | authorlink11 = Carmen Scheibenbogen | |||
| title = Frequent IgG subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome | url = https://www.sciencedirect.com/science/article/abs/pii/S0198885915004656 | |||
| journal = Human Immunology | volume = 76 | issue = 10 | page = 729-35 | date = 2015 | |||
| doi = 10.1016/j.humimm.2015.09.028}}</ref> - | |||
[https://www.sciencedirect.com/science/article/abs/pii/S0198885915004656 (Full Text)] | |||
*2015, Polymorphism in [[COMT]] is associated with IgG3 subclass level and susceptibility to infection in patients with chronic fatigue syndrome<ref name="Loebel2015">{{Cite journal | |||
| last1 = Loebel | first1 = Madlen | authorlink1 = Madlen Loebel | |||
| last2 = Mooslechner | first2 = Agnes Anna | authorlink2 = | |||
| last3 = Bauer | first3 = Sandra | authorlink3 = | |||
| last4 = Günther | first4 = Sabrina | authorlink4 = | |||
| last5 = Letsch | first5 = Anne | authorlink5 = | |||
| last6 = Hanitsch | first6 = Leif G | authorlink6 = | |||
| last7 = Grabowski | first7 = Patricia | authorlink7 = Patricia Grabowski | |||
| last8 = Meisel | first8 = Christian | authorlink8 = | |||
| last9 = Volk | first9 = Hans-Dieter | authorlink9 = | |||
| last10 = Scheibenbogen | first10 = Carmen | authorlink10 = Carmen Scheibenbogen | |||
| title = Polymorphism in COMT is associated with IgG3 subclass level and susceptibility to infection in patients with chronic fatigue syndrome | url = https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-015-0628-4 | |||
| journal = Journal of Translational Medicine | volume = 13 | issue = | page = 264 | date = 2015 | pmc = PMC4536662 | pmid = 26272340 | |||
| doi = 10.1186/s12967-015-0628-4 }} </ref> - [https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-015-0628-4 (Full Text)] | |||
*2016, Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome<ref name="Loebel2016">{{Cite journal | |||
| last1 = Loebel | first1 = M | authorlink1 = Madlen Loebel | |||
| last2 = Grabowski | first2 = P | authorlink2 = Patricia Grabowski | |||
| last3 = Heidecke | first3 = H | authorlink3 = | |||
| last4 = Bauer | first4 = S | authorlink4 = | |||
| last5 = Hanitsch | first5 = LG | authorlink5 = | |||
| last6 = Wittke | first6 = K | authorlink6 = | |||
| last7 = Meisel | first7 = C | authorlink7 = | |||
| last8 = Reinke | first8 = P | authorlink8 = | |||
| last9 = Volk | first9 = H | authorlink9 = | |||
| last10 = Fluge | first10 = Ø | authorlink10 = Øystein Fluge | |||
| last11 = Mella | first11 = O | authorlink11 = Olav Mella | |||
| last12 = Scheibenbogen | first12 = C | authorlink12 = Carmen Scheibenbogen | |||
| title = Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome | url = https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-015-0628-4 | |||
| journal = Brain, behavior, and immunity | volume = 52 | issue = | page = 32-39 | pmid = 26399744 | |||
| date = 2016 | |||
| doi = 10.1016/j.bbi.2015.09.013}}</ref> - [https://www.sciencedirect.com/science/article/pii/S0889159115300209?via%3Dihub (Full Text)] | |||
*2017, Serological profiling of the [[Epstein-Barr virus|EBV]] immune response in Chronic Fatigue Syndrome using a peptide microarray<ref name="Loebel2017">{{Cite journal | |||
| last1 = Loebel | first1 = Madlen | authorlink1 = Madlen Loebel | |||
| last2 = Eckey | first2 = Maren | authorlink2 = | |||
| last3 = Sotzny | first3 = Franziska | authorlink3 = Franziska Sotzny | |||
| last4 = Hahn | first4 = Elisabeth | authorlink4 = | |||
| last5 = Bauer | first5 = Sandra | authorlink5 = | |||
| last6 = Grabowski | first6 = Patricia | authorlink6 = Patricia Grabowski | |||
| last7 = Zerweck | first7 = Johannes | authorlink7 = | |||
| last8 = Holenya | first8 = Pavlo | authorlink8 = | |||
| last9 = Hanitsch | first9 = Leif G. | authorlink9 = | |||
| last10 = Wittke | first10 = Kirsten | authorlink10 = | |||
| last11 = Borchmann | first11 = Peter | authorlink11 = | |||
| last12 = Rüffer | first12 = Jens-Ulrich | authorlink12 = | |||
| last13 = Hiepe | first13 = Falk | authorlink13 = | |||
| last14 = Ruprecht | first14 = Klemens | authorlink14 = | |||
| last15 = Behrends | first15 = Uta | authorlink15 = | |||
| last16 = Meindl | first16 = Carola | authorlink16 = | |||
| last17 = Volk | first17 = Hans-Dieter | authorlink17= | |||
| last18 = Reimer | first18 = Ulf | authorlink18 = | |||
| last19 = Scheibenbogen | first19 = Carmen | authorlink19 = Carmen Scheibenbogen | |||
| title = Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray | url = https://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0179124 | |||
| journal = PLOS ONE | volume = 12 | issue = 6 | page = e0179124| date = 2017 | doi = 10.1371/journal.pone.0179124 }}</ref> - [https://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0179124 (Full Text)] | |||
*2017, The European ME/CFS [[Biomarker]] Landscape project: an initiative of the European network EUROMENE<ref name="EUROMENE2017">{{Cite journal|last=Scheibenbogen|first=Carmen|author-link=Carmen Scheibenbogen|last2=Freitag|first2=Helma|author-link2=Helma Freitag|last3=Blanco|first3=Julià|author-link3=Julià Blanco|last4=Capelli|first4=Enrica|author-link4=Enrica Capelli|last5=Lacerda|first5=Eliana|author-link5=Eliana Lacerda|last6=Authier|first6=Jerome|author-link6=François Jérôme Authier|last7=Meeus|first7=Mira|author-link7=Mira Meeus|last8=Castro Marrero|first8=Jesus|author-link8=Jesús Castro-Marrero|last9=Nora-Krukle|first9=Zaiga|author-link9=Zaiga Nora-Krukle|last10=Oltra|first10=Elisa|author-link10=Elisa Oltra|last11= Strand|first11=Elin Bolle|author-link11=Elin Bolle Strand|last12= Shikova|first12= Evelina|author-link12= Evelina Shikova|last13= Sekulic|first13=Slobodan|author-link13=Slobodan Sekulic|last14=Murovska|first14=Modra|author-link14=Modra Murovska|date=2017-07-26|title=The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE|url=https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-017-1263-z|journal=Journal of Translational Medicine|language=en|volume=15|issue=1|pages=|doi=10.1186/s12967-017-1263-z|issn=1479-5876|pmc=5530475|pmid=28747192|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530475/ (Full Text)] | |||
*2018, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – Evidence for an [[autoimmune disease]]<ref name="Sotzny2018">{{Cite journal | |||
| last1 = Sotzny | first1 = Franziska | authorlink1 = Franziska Sotzny | |||
| last2 = Blanco | first2 = Julià | authorlink2 = Julià Blanco | |||
| last3 = Capelli | first3 = Enrica | authorlink3 = Enrica Capelli | |||
| last4 = Castro-Marrero | first4 = Jesús | authorlink4 = Jesús Castro-Marrero | |||
| last5 = Steiner | first5 = Sophie | authorlink5 = | |||
| last6 = Murovska | first6 = Modra | authorlink6 = Modra Murovska | |||
| last7 = Scheibenbogen | first7 = Carmen | authorlink7 = Carmen Scheibenbogen | |||
| title = Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – Evidence for an autoimmune disease | url = https://www.sciencedirect.com/science/article/pii/S1568997218300880 | |||
| journal = Autoimmunity Reviews | volume = 17 | issue = 6 | page = 601-609 | |||
| date = 2018| pmid = 29635081 | doi = 10.1016/j.autrev.2018.01.009 }} </ref> - [https://www.sciencedirect.com/science/article/pii/S1568997218300880 (Full Text)] | |||
*2018, [[Immunoadsorption]] to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME<ref name="Immunoadsorption2018">{{Cite journal|last=Scheibenbogen|first=Carmen|author-link=Carmen Scheibenbogen|last2=Loebel|first2=Madlen|author-link2=Madlen Löbel|last3=Freitag|first3=Helma|author-link3=Helma Freitag|last4=Krueger|first4=Anne|last5=Bauer|first5=Sandra|author-link5=Sandra Bauer|last6=Antelmann|first6=Michaela|last7=Doehner|first7=Wolfram|last8=Scherbakov|first8=Nadja|last9=Heidecke|first9=Harald|last10=Reinke|first10=Petra|last11=Volk|first11=Hans-Dieter|last12=Grabowski|first12=Patricia|author-link12=Patricia Grabowski|date=2018|title=Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME|url=https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0193672|journal=PLoS ONE|volume=13|issue=3|pages=e0193672|doi=10.1371/journal.pone.0193672|via=}}</ref> - [https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0193672 (Full Text)] | |||
*2018, The expression signature of very long non-coding [[RNA]] in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="Yang2018">{{Cite journal|last=Yang|first=Chin-An|last2=Bauer|first2=Sandra|author-link2=Sandra Bauer|last3=Ho|first3=Yu-Chen|last4=Sotzny|first4=Franziska|author-link4=Franziska Sotzny|last5=Chang|first5=Jan-Gowth|last6=Scheibenbogen|first6=Carmen|author-link6=Carmen Scheibenbogen|date=2018-08-17|title=The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome|url=https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1600-x|journal=Journal of Translational Medicine|language=en|volume=16|issue=|pages=231|doi=10.1186/s12967-018-1600-x|issn=1479-5876|via=}}</ref> - [https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1600-x (Full Text)] | |||
* 2018, Prevalence and incidence of [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]] in Europe—the Euro-epiME study from the European network [[EUROMENE]]: a protocol for a systematic review<ref name="Lopez2018">{{Cite journal|last=Estévez-López|first=Fernando|author-link=Fernando Estévez-López|last2=Castro-Marrero|first2=Jesus|author-link2=Jesús Castro-Marrero|last3=Wang|first3=Xia|author-link3=Xia Wang-Steverding|last4=Bakken|first4=Inger Johanne|author-link4=Inger Johanne Bakken|last5=Ivanovs|first5=Andrejs|author-link5=Andrejs Ivanovs|last6=Nacul|first6=Luis|author-link6=Luis Nacul|last7=Sepúlveda|first7=Nuno|author-link7=Nuno Sepulveda|last8=Strand|first8=Elin B.|author-link8=Elin Strand|last9=Pheby|first9=Derek|author-link9=Derek Pheby|last10=Alegre|first10=José|author-link10=José Alegre|last11=Scheibenbogen|first11=Carmen|author-link11=Carmen Scheibenbogen|last12=Shikova|first12=Evelina|author-link12=Evelina Shikova|last13=Lorusso|first13=Lorenzo|author-link13=Lorenzo Lorusso|last14=Capelli|first14=Enrica|author-link14=Enrica Capelli|last15=Sekulic|first15=Slobodan|author-link15=Slobodan Sekulic|last16=Lacerda|first16=Eliana|author-link16=Eliana Lacerda|last17=Murovska|first17=Modra|author-link17=Modra Murovska|date=2018-09-01|title=Prevalence and incidence of myalgic encephalomyelitis/chronic fatigue syndrome in Europe—the Euro-epiME study from the European network EUROMENE: a protocol for a systematic review|url=https://bmjopen.bmj.com/content/8/9/e020817|journal=BMJ Open|language=en|volume=8|issue=9|pages=e020817|doi=10.1136/bmjopen-2017-020817|issn=2044-6055|pmc=|pmid=30181183|via=}}</ref> - [https://bmjopen.bmj.com/content/8/9/e020817 (Full text)] | |||
*2018, Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)<ref name="Rasa2018">{{Cite journal|last=Rasa|first=Santa|author-link=Santa Rasa|last2=Nora-Krukle|first2=Zaiga|author-link2=Zaiga Nora-Krukle|last3=Henning|first3=Nina|author-link3=|last4=Eliassen|first4=Eva|author-link4=|last5=Shikova|first5=Evelina|author-link5=Evelina Shikova|last6=Harrer|first6=Thomas|author-link6=Thomas Harrer|last7=Scheibenbogen|first7=Carmen|author-link7=Carmen Scheibenbogen|last8=Murovska|first8=Modra|author-link8=Modra Murovska|last9=Prusty|first9=Bhupesh K.|author-link9=Bhupesh Prusty|last10=European Network on ME/CFS (EUROMENE)|first10=|author-link10=EUROMENE|date=2018-10-01|title=Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)|url=https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1644-y|journal=Journal of Translational Medicine|language=en|volume=16|issue=1|pages=|doi=10.1186/s12967-018-1644-y|issn=1479-5876|pmc=|pmid=30285773|quote=|via=}}</ref> - [https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1644-y (Full text)] | |||
*2020, IgG stimulated β2 adrenergic receptor activation is attenuated in patients with ME/CFS<ref name="IgG2020">{{Cite journal|last=Hartwig|first=Jelka|last2=Sotzny|first2=Franziska|author-link2=Franziska Sotzny|last3=Bauer|first3=Sandra|author-link3=Sandra Bauer|last4=Heidecke|first4=Harald|last5=Riemekasten|first5=Gabriela|last6=Dragun|first6=Duska|last7=Meisel|first7=Christian|last8=Dames|first8=Claudia|last9=Grabowski|first9=Patricia|author-link9=Patricia Grabowski|last10=Scheibenbogen|first10=Carmen|date=2020-03-01|title=IgG stimulated β2 adrenergic receptor activation is attenuated in patients with ME/CFS|url=http://www.sciencedirect.com/science/article/pii/S2666354620300120|journal=Brain, Behavior, & Immunity - Health|language=en|volume=3|pages=100047|doi=10.1016/j.bbih.2020.100047|issn=2666-3546}}</ref> - [https://www.sciencedirect.com/science/article/pii/S2666354620300120 (Full text)] | *2020, IgG stimulated β2 adrenergic receptor activation is attenuated in patients with ME/CFS<ref name="IgG2020">{{Cite journal|last=Hartwig|first=Jelka|last2=Sotzny|first2=Franziska|author-link2=Franziska Sotzny|last3=Bauer|first3=Sandra|author-link3=Sandra Bauer|last4=Heidecke|first4=Harald|last5=Riemekasten|first5=Gabriela|last6=Dragun|first6=Duska|last7=Meisel|first7=Christian|last8=Dames|first8=Claudia|last9=Grabowski|first9=Patricia|author-link9=Patricia Grabowski|last10=Scheibenbogen|first10=Carmen|date=2020-03-01|title=IgG stimulated β2 adrenergic receptor activation is attenuated in patients with ME/CFS|url=http://www.sciencedirect.com/science/article/pii/S2666354620300120|journal=Brain, Behavior, & Immunity - Health|language=en|volume=3|pages=100047|doi=10.1016/j.bbih.2020.100047|issn=2666-3546}}</ref> - [https://www.sciencedirect.com/science/article/pii/S2666354620300120 (Full text)] | ||
*2020, Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref name="Schreiner2020">{{Cite journal|last=Schreiner|first=Philipp|author-link=|last2=Harrer|first2=Thomas|author-link2=Thomas Harrer|last3=Scheibenbogen|first3=Carmen|author-link3=Carmen Scheibenbogen|last4=Lamer|first4=Stephanie|author-link4=|last5=Schlosser|first5=Andreas|author-link5=|last6=Naviaux|first6=Robert K.|author-link6=Robert Naviaux|last7=Prusty|first7=Bhupesh K.|author-link7=Bhupesh Prusty|date=2020-04-01|title=Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|url=https://www.immunohorizons.org/content/4/4/201|journal=ImmunoHorizons|language=en|volume=4|issue=4|pages=201–215|doi=10.4049/immunohorizons.2000006|issn=2573-7732|pmc=|pmid=32327453|access-date=|quote=|via=}}</ref> - [https://www.immunohorizons.org/content/4/4/201 (Full text)] | *2020, Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref name="Schreiner2020">{{Cite journal|last=Schreiner|first=Philipp|author-link=|last2=Harrer|first2=Thomas|author-link2=Thomas Harrer|last3=Scheibenbogen|first3=Carmen|author-link3=Carmen Scheibenbogen|last4=Lamer|first4=Stephanie|author-link4=|last5=Schlosser|first5=Andreas|author-link5=|last6=Naviaux|first6=Robert K.|author-link6=Robert Naviaux|last7=Prusty|first7=Bhupesh K.|author-link7=Bhupesh Prusty|date=2020-04-01|title=Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|url=https://www.immunohorizons.org/content/4/4/201|journal=ImmunoHorizons|language=en|volume=4|issue=4|pages=201–215|doi=10.4049/immunohorizons.2000006|issn=2573-7732|pmc=|pmid=32327453|access-date=|quote=|via=}}</ref> - [https://www.immunohorizons.org/content/4/4/201 (Full text)] | ||
* 2020, Systematic Review of the Epidemiological Burden of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Across Europe: Current Evidence and EUROMENE Research Recommendations for Epidemiology<ref name="Estevez-Lopez2020">{{Cite journal|last=Estévez-López|first=Fernando|author-link=Fernando Estévez-López|last2=Mudie|first2=Kathleen|author-link2=|last3=Wang-Steverding|first3=Xia|author-link3=Xia Wang-Steverding|last4=Bakken|first4=Inger Johanne|author-link4=Inger Johanne Bakken|last5=Ivanovs|first5=Andrejs|author-link5=|last6=Castro-Marrero|first6=Jesús|author-link6=Jesús Castro-Marrero|last7=Nacul|first7=Luis|author-link7=Luis Nacul|last8=Alegre|first8=Jose|author-link8=José Alegre|last9=Zalewski|first9=Paweł|last10=Słomko|first10=Joanna|author-link10=|last11=Bolle Strand|first11=Elin|author-link11=Elin Bolle Strand|last12=Pheby|first12=Derek|author-link12=Derek Pheby|last13=Shikova|first13=Evelina|author-link13=Evelina Shikova|last14=Lorusso|first14=Lorenzo|author-link14=Lorenzo Lorusso|last15=Capelli|first15=Enrica|author-link15=Enrica Capelli|last16=Sekulic|first16=Slobodan|author-link16=Slobodan Sekulic|last17=Scheibenbogen|first17=Carmen|author-link17=Carmen Scheibenbogen|last18=Sepúlveda|first18=Nuno|author-link18=Nuno Sepúlveda|last19=Murovska|first19=Modra|author-link19=Modra Murovska|last20=Lacerda|first20=Eliana|authorlink20=Eliana Lacerda|others=(EUROMENE)|date=May 2020|title=Systematic Review of the Epidemiological Burden of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Across Europe: Current Evidence and EUROMENE Research Recommendations for Epidemiology|url=https://www.mdpi.com/2077-0383/9/5/1557|journal=Journal of Clinical Medicine|language=en|volume=9|issue=5|pages=1557|doi=10.3390/jcm9051557|pmc=|pmid=|quote=|access-date=|via=}}</ref> - [https://www.mdpi.com/2077-0383/9/5/1557/htm (Full text)] | * 2020, Systematic Review of the Epidemiological Burden of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Across Europe: Current Evidence and EUROMENE Research Recommendations for Epidemiology<ref name="Estevez-Lopez2020">{{Cite journal|last=Estévez-López|first=Fernando|author-link=Fernando Estévez-López|last2=Mudie|first2=Kathleen|author-link2=|last3=Wang-Steverding|first3=Xia|author-link3=Xia Wang-Steverding|last4=Bakken|first4=Inger Johanne|author-link4=Inger Johanne Bakken|last5=Ivanovs|first5=Andrejs|author-link5=|last6=Castro-Marrero|first6=Jesús|author-link6=Jesús Castro-Marrero|last7=Nacul|first7=Luis|author-link7=Luis Nacul|last8=Alegre|first8=Jose|author-link8=José Alegre|last9=Zalewski|first9=Paweł|last10=Słomko|first10=Joanna|author-link10=|last11=Bolle Strand|first11=Elin|author-link11=Elin Bolle Strand|last12=Pheby|first12=Derek|author-link12=Derek Pheby|last13=Shikova|first13=Evelina|author-link13=Evelina Shikova|last14=Lorusso|first14=Lorenzo|author-link14=Lorenzo Lorusso|last15=Capelli|first15=Enrica|author-link15=Enrica Capelli|last16=Sekulic|first16=Slobodan|author-link16=Slobodan Sekulic|last17=Scheibenbogen|first17=Carmen|author-link17=Carmen Scheibenbogen|last18=Sepúlveda|first18=Nuno|author-link18=Nuno Sepúlveda|last19=Murovska|first19=Modra|author-link19=Modra Murovska|last20=Lacerda|first20=Eliana|authorlink20=Eliana Lacerda|others=(EUROMENE)|date=May 2020|title=Systematic Review of the Epidemiological Burden of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Across Europe: Current Evidence and EUROMENE Research Recommendations for Epidemiology|url=https://www.mdpi.com/2077-0383/9/5/1557|journal=Journal of Clinical Medicine|language=en|volume=9|issue=5|pages=1557|doi=10.3390/jcm9051557|pmc=|pmid=|quote=|access-date=|via=}}</ref> - [https://www.mdpi.com/2077-0383/9/5/1557/htm (Full text)] | ||
* 2020, Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome<ref name="endothelial2020">{{Cite journal|last=Scherbakov|first=Nadja|author-link=|last2=Szklarski|first2=Marvin|author-link2=|last3=Hartwig|first3=Jelka|author-link3=|last4=Sotzny|first4=Franziska|author-link4=Franziska Sotzny|last5=Lorenz|first5=Sebastian|author-link5=|last6=Meyer|first6=Antje|author-link6=|last7=Grabowski|first7=Patricia|author-link7=Patricia Grabowski|last8=Doehner|first8=Wolfram|last9=Scheibenbogen|first9=Carmen|author-link9=Carmen Scheibenbogen|date=2020|title=Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome|url=https://onlinelibrary.wiley.com/doi/abs/10.1002/ehf2.12633|journal=ESC Heart Failure|language=en|volume=7|issue=3|pages=1064–1071|doi=10.1002/ehf2.12633|issn=2055-5822|pmc = 7261521|pmid=32154656|access-date=|quote=|via=}}</ref> - [https://onlinelibrary.wiley.com/doi/abs/10.1002/ehf2.12633 (Full text)] | * 2020, Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome<ref name="endothelial2020">{{Cite journal|last=Scherbakov|first=Nadja|author-link=|last2=Szklarski|first2=Marvin|author-link2=|last3=Hartwig|first3=Jelka|author-link3=|last4=Sotzny|first4=Franziska|author-link4=Franziska Sotzny|last5=Lorenz|first5=Sebastian|author-link5=|last6=Meyer|first6=Antje|author-link6=|last7=Grabowski|first7=Patricia|author-link7=Patricia Grabowski|last8=Doehner|first8=Wolfram|last9=Scheibenbogen|first9=Carmen|author-link9=Carmen Scheibenbogen|date=2020|title=Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome|url=https://onlinelibrary.wiley.com/doi/abs/10.1002/ehf2.12633|journal=ESC Heart Failure|language=en|volume=7|issue=3|pages=1064–1071|doi=10.1002/ehf2.12633|issn=2055-5822|pmc = 7261521|pmid=32154656|access-date=|quote=|via=}}</ref> - [https://onlinelibrary.wiley.com/doi/abs/10.1002/ehf2.12633 (Full text)] | ||
*2020, Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated With ME/CFS With Infectious Onset<ref name="Steiner2021">{{Cite journal|last=Steiner|first=Sophie|last2=Becker|first2=Sonya C.|last3=Hartwig|first3=Jelka|last4=Sotzny|first4=Franziska|last5=Lorenz|first5=Sebastian|last6=Bauer|first6=Sandra|author-link6=Sandra Bauer|last7=Löbel|first7=Madlen|last8=Stittrich|first8=Anna B.|last9=Grabowski|first9=Patricia|author-link9=Patricia Grabowski|last10=Scheibenbogen|first10=Carmen|date=2020|title=Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated With ME/CFS With Infectious Onset|url=https://www.frontiersin.org/article/10.3389/fimmu.2020.00578|journal=Frontiers in Immunology|volume=11|pages=578|doi=10.3389/fimmu.2020.00578|issn=1664-3224}}</ref> - [https://www.frontiersin.org/articles/10.3389/fimmu.2020.00578/full (Full text)] | *2020, Autoimmunity-Related Risk Variants in [[PTPN22]] and [[CTLA4]] Are Associated With ME/CFS With Infectious Onset<ref name="Steiner2021">{{Cite journal|last=Steiner|first=Sophie|last2=Becker|first2=Sonya C.|last3=Hartwig|first3=Jelka|last4=Sotzny|first4=Franziska|last5=Lorenz|first5=Sebastian|last6=Bauer|first6=Sandra|author-link6=Sandra Bauer|last7=Löbel|first7=Madlen|last8=Stittrich|first8=Anna B.|last9=Grabowski|first9=Patricia|author-link9=Patricia Grabowski|last10=Scheibenbogen|first10=Carmen|date=2020|title=Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated With ME/CFS With Infectious Onset|url=https://www.frontiersin.org/article/10.3389/fimmu.2020.00578|journal=Frontiers in Immunology|volume=11|pages=578|doi=10.3389/fimmu.2020.00578|issn=1664-3224}}</ref> - [https://www.frontiersin.org/articles/10.3389/fimmu.2020.00578/full (Full text)] | ||
*2020, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Efficacy of Repeat Immunoadsorption<ref name="Tolle2020">{{Cite journal|last=Tölle|first=Markus|author-link=Markus Tölle|last2=Freitag|first2=Helma|author-link2=Helma Freitag|last3=Antelmann|first3=Michaela|last4=Hartwig|first4=Jelka|last5=Schuchardt|first5=Mirjam|last6=van der Giet|first6=Markus|last7=Eckardt|first7=Kai-Uwe|last8=Grabowski|first8=Patricia|author-link8=Patricia Grabowski|last9=Scheibenbogen|first9=Carmen|author-link9=Carmen Scheibenbogen|date=2020-07-30|title=Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Efficacy of Repeat Immunoadsorption|url=https://www.mdpi.com/2077-0383/9/8/2443|journal=Journal of Clinical Medicine|language=en|volume=9|issue=8|pages=2443|doi=10.3390/jcm9082443|issn=2077-0383|pmc=PMC7465279|pmid=32751659}}</ref> - [https://doi.org/10.3390/jcm9082443 (Full text)] | *2020, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Efficacy of Repeat Immunoadsorption<ref name="Tolle2020">{{Cite journal|last=Tölle|first=Markus|author-link=Markus Tölle|last2=Freitag|first2=Helma|author-link2=Helma Freitag|last3=Antelmann|first3=Michaela|last4=Hartwig|first4=Jelka|last5=Schuchardt|first5=Mirjam|last6=van der Giet|first6=Markus|last7=Eckardt|first7=Kai-Uwe|last8=Grabowski|first8=Patricia|author-link8=Patricia Grabowski|last9=Scheibenbogen|first9=Carmen|author-link9=Carmen Scheibenbogen|date=2020-07-30|title=Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Efficacy of Repeat Immunoadsorption|url=https://www.mdpi.com/2077-0383/9/8/2443|journal=Journal of Clinical Medicine|language=en|volume=9|issue=8|pages=2443|doi=10.3390/jcm9082443|issn=2077-0383|pmc=PMC7465279|pmid=32751659}}</ref> - [https://doi.org/10.3390/jcm9082443 (Full text)] | ||
*2020, A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors<ref name="Wirth2020a">{{Cite journal|last=Wirth|first=Klaus|author-link=Klaus Wirth|last2=Scheibenbogen|first2=Carmen|author-link2=Carmen Scheibenbogen|date=2020-06-01|title=A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors|url=https://www.sciencedirect.com/science/article/pii/S1568997220300823|journal=Autoimmunity Reviews|language=en|volume=19|issue=6|pages=102527|doi=10.1016/j.autrev.2020.102527|issn=1568-9972}}</ref> - [https://doi.org/10.1016/j.autrev.2020.102527 (Full text)] | *2020, A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors<ref name="Wirth2020a">{{Cite journal|last=Wirth|first=Klaus|author-link=Klaus Wirth|last2=Scheibenbogen|first2=Carmen|author-link2=Carmen Scheibenbogen|date=2020-06-01|title=A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors|url=https://www.sciencedirect.com/science/article/pii/S1568997220300823|journal=Autoimmunity Reviews|language=en|volume=19|issue=6|pages=102527|doi=10.1016/j.autrev.2020.102527|issn=1568-9972}}</ref> - [https://doi.org/10.1016/j.autrev.2020.102527 (Full text)] | ||
*2020, Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients - A validation study in plasma and cerebrospinal fluid from two Swedish cohorts<ref name="Bynke2020">{{Cite journal|last=Bynke|first=Annie|author-link=|last2=Julin|first2=Per|author-link2=|last3=Gottfries|first3=Carl-Gerhard|author-link3=Carl-Gerhard Gottfries|last4=Heidecke|first4=Harald|author-link4=|last5=Scheibenbogen|first5=Carmen|author-link5=Carmen Scheibenbogen|last6=Bergquist|first6=Jonas|author-link6=Jonas Bergquist|date=Aug 2020|title=Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients - A validation study in plasma and cerebrospinal fluid from two Swedish cohorts|url=https:// | *2020, Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients - A validation study in plasma and cerebrospinal fluid from two Swedish cohorts<ref name="Bynke2020">{{Cite journal|last=Bynke|first=Annie|author-link=|last2=Julin|first2=Per|author-link2=|last3=Gottfries|first3=Carl-Gerhard|author-link3=Carl-Gerhard Gottfries|last4=Heidecke|first4=Harald|author-link4=|last5=Scheibenbogen|first5=Carmen|author-link5=Carmen Scheibenbogen|last6=Bergquist|first6=Jonas|author-link6=Jonas Bergquist|date=Aug 2020|title=Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients - A validation study in plasma and cerebrospinal fluid from two Swedish cohorts|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474431|journal=Brain, Behavior, & Immunity - Health|volume=7|issue=|pages=100107|doi=10.1016/j.bbih.2020.100107|issn=2666-3546|pmc=8474431|pmid=34589868|access-date=|quote=|via=}}</ref> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474431 (Full text)] | ||
*2021, Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)<ref name="Wirth2021a">{{Cite journal|last=Wirth|first=Klaus J.|author-link=Klaus Wirth|last2=Scheibenbogen|first2=Carmen|author-link2=Carmen Scheibenbogen |date=2021-04-21|title=Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)|url=https://doi.org/10.1186/s12967-021-02833-2|journal=Journal of Translational Medicine|volume=19|issue=1|pages=162|doi=10.1186/s12967-021-02833-2|issn=1479-5876|pmc=PMC8058748|pmid=33882940}}</ref> - [https://doi.org/10.1186/s12967-021-02833-2 (Full text)] | *2021, Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)<ref name="Wirth2021a">{{Cite journal|last=Wirth|first=Klaus J.|author-link=Klaus Wirth|last2=Scheibenbogen|first2=Carmen|author-link2=Carmen Scheibenbogen |date=2021-04-21|title=Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)|url=https://doi.org/10.1186/s12967-021-02833-2|journal=Journal of Translational Medicine|volume=19|issue=1|pages=162|doi=10.1186/s12967-021-02833-2|issn=1479-5876|pmc=PMC8058748|pmid=33882940}}</ref> - [https://doi.org/10.1186/s12967-021-02833-2 (Full text)] | ||
* 2021, The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: analysis of high-throughput epigenetic and gene expression studies<ref>{{Cite journal|last=Malato|first=João|author-link=|last2=Sotzny|first2=Franziska|author-link2=Franziska Sotzny|last3=Bauer|first3=Sandra|author-link3=Sandra Bauer|last4=Freitag|first4=Helma|author-link4=Helma Freitag|last5=Fonseca|first5=André|author-link5=|last6=Grabowska|first6=Anna D|author-link6=|last7=Graça|first7=Luís|last8=Cordeiro|first8=Clara|last9=Nacul|first9=Luís|author-link9=Luis Nacul|last10=Lacerda|first10=Eliana M|author-link10=Eliana Lacerda|last11=Castro-Marrero|first11=Jesus|author-link11=Jesus Castro-Marrero|last12=Scheibenbogen|first12=Carmen|author-link12=Carmen Scheibenbogen|last13=Westermeier|first13=Francisco|author-link13=|last14=Sepúlveda|first14=Nuno|author-link14=Nuno Sepúlveda|date=2021-03-24|title=The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: analysis of high-throughput epigenetic and gene expression studies|url=http://medrxiv.org/lookup/doi/10.1101/2021.03.23.21254175|journal=medRxiv|language=en|volume=|issue=|pages=|doi=10.1101/2021.03.23.21254175|pmc=|pmid=33791744|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010776/ (Full text)] | * 2021, The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: analysis of high-throughput epigenetic and gene expression studies<ref name="Malato2021">{{Cite journal|last=Malato|first=João|author-link=|last2=Sotzny|first2=Franziska|author-link2=Franziska Sotzny|last3=Bauer|first3=Sandra|author-link3=Sandra Bauer|last4=Freitag|first4=Helma|author-link4=Helma Freitag|last5=Fonseca|first5=André|author-link5=|last6=Grabowska|first6=Anna D|author-link6=|last7=Graça|first7=Luís|last8=Cordeiro|first8=Clara|last9=Nacul|first9=Luís|author-link9=Luis Nacul|last10=Lacerda|first10=Eliana M|author-link10=Eliana Lacerda|last11=Castro-Marrero|first11=Jesus|author-link11=Jesus Castro-Marrero|last12=Scheibenbogen|first12=Carmen|author-link12=Carmen Scheibenbogen|last13=Westermeier|first13=Francisco|author-link13=|last14=Sepúlveda|first14=Nuno|author-link14=Nuno Sepúlveda|date=2021-03-24|title=The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: analysis of high-throughput epigenetic and gene expression studies|url=http://medrxiv.org/lookup/doi/10.1101/2021.03.23.21254175|journal=medRxiv|language=en|volume=|issue=|pages=|doi=10.1101/2021.03.23.21254175|pmc=|pmid=33791744|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010776/ (Full text)] | ||
*2021, European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe<ref name="Nacul2021">{{Cite journal|last=Nacul|first=Luis|author-link=Luis Nacul|last2=Authier|first2=François Jérôme|author-link2=François Jérôme Authier|last3=Scheibenbogen|first3=Carmen|author-link3=Carmen Scheibenbogen|last4=Lorusso|first4=Lorenzo|author-link4=Lorenzo Lorusso|last5=Helland|first5=Ingrid Bergliot|author-link5=|last6=Martin|first6=Jose Alegre|author-link6=José Alegre|last7=Sirbu|first7=Carmen Adella|last8=Mengshoel|first8=Anne Marit|last9=Polo|first9=Olli | *2021, European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe<ref name="Nacul2021">{{Cite journal|last=Nacul|first=Luis|author-link=Luis Nacul|last2=Authier|first2=François Jérôme|author-link2=François Jérôme Authier|last3=Scheibenbogen|first3=Carmen|author-link3=Carmen Scheibenbogen|last4=Lorusso|first4=Lorenzo|author-link4=Lorenzo Lorusso|last5=Helland|first5=Ingrid Bergliot|author-link5=|last6=Martin|first6=Jose Alegre|author-link6=José Alegre|last7=Sirbu|first7=Carmen Adella|last8=Mengshoel|first8=Anne Marit|last9=Polo|first9=Olli | ||
|first10=Uta|last10=Behrends|author-link10=Uta Behrends | |first10=Uta|last10=Behrends|author-link10=Uta Behrends | ||
| Line 54: | Line 150: | ||
|first25=Modra|last25=Murovska | |first25=Modra|last25=Murovska | ||
|first26=Ruud C. W.|last26=Vermuelen|authorlink26=Ruud Vermuelen | |first26=Ruud C. W.|last26=Vermuelen|authorlink26=Ruud Vermuelen | ||
|first27=Eliana M.|last27=Lacerda|authorlink27=Eliana Lacerda|others=(EUROMENE)|date=May 2021|title=European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe|url=https://www. | |first27=Eliana M.|last27=Lacerda|authorlink27=Eliana Lacerda|others=(EUROMENE)|date=May 2021|title=European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161074|journal=Medicina|language=en|volume=57|issue=5|pages=510|doi=10.3390/medicina57050510|pmc=PMC8161074|pmid=34069603|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161074 (Full text)] | ||
*2021, Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref name="Freitag2021">{{Cite journal|last=Freitag|first=Helma|author-link=Helma Freitag|last2=Szklarski|first2=Marvin|author-link2=|last3=Lorenz|first3=Sebastian|author-link3=|last4=Sotzny|first4=Franziska|author-link4=Franziska Sotzny|last5=Bauer|first5=Sandra|author-link5=Sandra Bauer|last6=Philippe|first6=Aurélie|author-link6=|last7=Kedor|first7=Claudia|last8=Grabowski|first8=Patricia|author-link8=Patricia Grabowski|last9=Lange|first9=Tanja|last10=Riemekasten|first10=Gabriela|last11=Heidecke|first11=Harald|last12=Scheibenbogen|first12=Carmen|author-link12=Carmen Scheibenbogen|date=Jan 2021|title=Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|url=https://www. | *2021, Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref name="Freitag2021">{{Cite journal|last=Freitag|first=Helma|author-link=Helma Freitag|last2=Szklarski|first2=Marvin|author-link2=|last3=Lorenz|first3=Sebastian|author-link3=|last4=Sotzny|first4=Franziska|author-link4=Franziska Sotzny|last5=Bauer|first5=Sandra|author-link5=Sandra Bauer|last6=Philippe|first6=Aurélie|author-link6=|last7=Kedor|first7=Claudia|last8=Grabowski|first8=Patricia|author-link8=Patricia Grabowski|last9=Lange|first9=Tanja|last10=Riemekasten|first10=Gabriela|last11=Heidecke|first11=Harald|last12=Scheibenbogen|first12=Carmen|author-link12=Carmen Scheibenbogen|date=Jan 2021|title=Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397061/|journal=Journal of Clinical Medicine|language=en|volume=10|issue=16|pages=3675|doi=10.3390/jcm10163675|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397061/ (Full text)] | ||
*2021, Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept Study<ref name="Scheibenbogen2021a">{{Cite journal|last=Scheibenbogen|first=Carmen|author-link=Carmen Scheibenbogen|last2=Sotzny|first2=Franziska|author-link2=Franziska Sotzny|last3=Hartwig|first3=Jelka|author-link3=|last4=Bauer|first4=Sandra|author-link4=Sandra Bauer|last5=Freitag|first5=Helma|author-link5=Helma Freitag|last6=Wittke|first6=Kirsten|author-link6=|last7=Doehner|first7=Wolfram|last8=Scherbakov|first8=Nadja|last9=Loebel|first9=Madlen|last10=Grabowski|first10=Patricia Grabowski|author-link10=Patricia Grabowski|date=Jan 2021|title=Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept Study|url=https://www. | *2021, Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept Study<ref name="Scheibenbogen2021a">{{Cite journal|last=Scheibenbogen|first=Carmen|author-link=Carmen Scheibenbogen|last2=Sotzny|first2=Franziska|author-link2=Franziska Sotzny|last3=Hartwig|first3=Jelka|author-link3=|last4=Bauer|first4=Sandra|author-link4=Sandra Bauer|last5=Freitag|first5=Helma|author-link5=Helma Freitag|last6=Wittke|first6=Kirsten|author-link6=|last7=Doehner|first7=Wolfram|last8=Scherbakov|first8=Nadja|last9=Loebel|first9=Madlen|last10=Grabowski|first10=Patricia Grabowski|author-link10=Patricia Grabowski|date=Jan 2021|title=Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept Study|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198960/|journal=Journal of Clinical Medicine|language=en|volume=10|issue=11|pages=2420|doi=10.3390/jcm10112420|pmc=PMC8198960|pmid=34072494|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198960/ (Full text)] | ||
*2021, Medical Care Situation of People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Germany<ref name="Froehlich2021">{{Cite journal|last=Froehlich|first=Laura|author-link=|last2=Hattesohl|first2=Daniel B. R.|author-link2=|last3=Jason|first3=Leonard A.|author-link3=Leonard Jason|last4=Scheibenbogen|first4=Carmen|author-link4=Carmen Scheibenbogen|last5=Behrends|first5=Uta|author-link5=Uta Behrends|last6=Thoma|first6=Manuel|author-link6=|date=Jul 2021|title=Medical Care Situation of People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Germany|url=https://www. | *2021, Medical Care Situation of People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Germany<ref name="Froehlich2021">{{Cite journal|last=Froehlich|first=Laura|author-link=|last2=Hattesohl|first2=Daniel B. R.|author-link2=|last3=Jason|first3=Leonard A.|author-link3=Leonard Jason|last4=Scheibenbogen|first4=Carmen|author-link4=Carmen Scheibenbogen|last5=Behrends|first5=Uta|author-link5=Uta Behrends|last6=Thoma|first6=Manuel|author-link6=|date=Jul 2021|title=Medical Care Situation of People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Germany|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306083/|journal=Medicina|language=en|volume=57|issue=7|pages=646|doi=10.3390/medicina57070646|pmc=PMC8306083|pmid=34201825|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306083/ (Full text)] | ||
*2021, An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref name="Wirth2021b">{{Cite journal|last=Wirth|first=Klaus J.|author-link=|last2=Scheibenbogen|first2=Carmen|author-link2=Carmen Scheibenbogen|last3=Paul|first3=Friedemann|author-link3=|date=2021-11-22|title=An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|url=https:// | *2021, An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref name="Wirth2021b">{{Cite journal|last=Wirth|first=Klaus J.|author-link=Klaus Wirth|last2=Scheibenbogen|first2=Carmen|author-link2=Carmen Scheibenbogen|last3=Paul|first3=Friedemann|author-link3=|date=2021-11-22|title=An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|url=https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-021-03143-3|journal=Journal of Translational Medicine|volume=19|issue=1|pages=471|doi=10.1186/s12967-021-03143-3|issn=1479-5876|pmc=PMC8607226|pmid=34809664|access-date=|quote=|via=}}</ref> - [https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-021-03143-3 (Full text)] | ||
*2021, S1 Guideline Post-COVID/Long-COVID | *2021, S1 Guideline Post-COVID/Long-COVID<ref name="Koczulla2021">{{Cite journal|last=Koczulla|first=Andreas Rembert|author-link=|last2=Ankermann|first2=Tobias|author-link2=|last3=Behrends|first3=Uta|author-link3=Uta Behrends|last4=Berlit|first4=Peter|author-link4=|last5=Böing|first5=Sebastian|author-link5=|last6=Brinkmann|first6=Folke|author-link6=|last7=Franke|first7=Christian|last8=Glöckl|first8=Rainer|last9=Gogoll|first9=Christian | ||
|last10=Hummel|first10=Thomas|last11=Kronsbein|first11=Juliane|last12=Maibaum|first12=Thomas|last13=Peters|first13=Eva M. J. | |last10=Hummel|first10=Thomas|last11=Kronsbein|first11=Juliane|last12=Maibaum|first12=Thomas|last13=Peters|first13=Eva M. J. | ||
|last14=Pfeifer|first14=Michael|last15=Platz|first15=Thomas|last16=Pletz|first16=Matthias|last17=Pongratz|first17=Georg | |last14=Pfeifer|first14=Michael|last15=Platz|first15=Thomas|last16=Pletz|first16=Matthias|last17=Pongratz|first17=Georg | ||
|last18=Powitz|first18=Frank|last19=Rabe|first19=Klaus F.|last20=Scheibenbogen|first20=Carmen|authorlink20=Carmen Scheibenbogen|last21=Stallmach|first21=Andreas|last22=Stegbauer|first22=Michael|last23=Wagner|first23=Hans Otto|last24=Waller|first24=Christiane|last25=Wirtz|first25=Hubert|last26=Zeiher|first26=Andreas|last27=Zwick|first27=Ralf Harun | |last18=Powitz|first18=Frank|last19=Rabe|first19=Klaus F.|last20=Scheibenbogen|first20=Carmen|authorlink20=Carmen Scheibenbogen|last21=Stallmach|first21=Andreas|last22=Stegbauer|first22=Michael|last23=Wagner|first23=Hans Otto|last24=Waller|first24=Christiane|last25=Wirtz|first25=Hubert|last26=Zeiher|first26=Andreas|last27=Zwick|first27=Ralf Harun | ||
|date=Nov 2021|title=S1-Leitlinie Post-COVID/Long-COVID|trans-title=S1 Guideline Post-COVID/Long-COVID|url=http://www.thieme-connect.de/DOI/DOI?10.1055/a-1551-9734|journal=Pneumologie|language=de|volume=75|issue=11|pages=869–900|doi=10.1055/a-1551-9734|issn=0934-8387|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://www.thieme-connect.com/DOI/DOI?10.1055/a-1551-9734 (Full text, in German)] | |date=Nov 2021|title=S1-Leitlinie Post-COVID/Long-COVID|trans-title=S1 Guideline Post-COVID/Long-COVID|url=http://www.thieme-connect.de/DOI/DOI?10.1055/a-1551-9734|journal=Pneumologie|language=de|volume=75|issue=11|pages=869–900|doi=10.1055/a-1551-9734|issn=0934-8387|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://www.thieme-connect.com/DOI/DOI?10.1055/a-1551-9734 (Full text, in German)] | ||
*2021, Causal attributions and perceived stigma for myalgic encephalomyelitis/chronic fatigue syndrome<ref name="Froehlich2020">{{Cite journal|last=Froehlich|first=Laura|author-link=|last2=Hattesohl|first2=Daniel Br|author-link2=|last3=Cotler|first3=Joseph|author-link3=|last4=Jason|first4=Leonard A.|author-link4=Leonard Jason|last5=Scheibenbogen|first5=Carmen|author-link5=Carmen Scheibenbogen|last6=Behrends|first6=Uta|author-link6=Uta Behrends | *2021, Causal attributions and perceived stigma for myalgic encephalomyelitis/chronic fatigue syndrome<ref name="Froehlich2020">{{Cite journal|last=Froehlich|first=Laura|author-link=|last2=Hattesohl|first2=Daniel Br|author-link2=|last3=Cotler|first3=Joseph|author-link3=|last4=Jason|first4=Leonard A.|author-link4=Leonard Jason|last5=Scheibenbogen|first5=Carmen|author-link5=Carmen Scheibenbogen|last6=Behrends|first6=Uta|author-link6=Uta Behrends|date=2021-07-09|title=Causal attributions and perceived stigma for myalgic encephalomyelitis/chronic fatigue syndrome|url=https://journals.sagepub.com/doi/10.1177/13591053211027631?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed|journal=Journal of Health Psychology|volume=|issue=|pages=13591053211027631|doi=10.1177/13591053211027631|issn=1461-7277|pmc=|pmid=34240650|access-date=|quote=|via=}}</ref> - [https://journals.sagepub.com/doi/10.1177/13591053211027631?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed (Full text)] | ||
*2021, Herpesviruses Serology Distinguishes Different Subgroups of Patients From the United Kingdom Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Biobank<ref name="Domingues2021">{{Cite journal|last=Domingues|first=Tiago Dias|author-link=|last2=Grabowska|first2=Anna D.|author-link2=|last3=Lee|first3=Ji-Sook|author-link3=|last4=Ameijeiras-Alonso|first4=Jose|author-link4=|last5=Westermeier|first5=Francisco|author-link5=|last6=Scheibenbogen|first6=Carmen|author-link6=Carmen Scheibenbogen|last7=Cliff|first7=Jacqueline M.|author-link7=Jacqueline Cliff|last8=Nacul|first8=Luis|author-link8=Luis Nacul|last9=Lacerda|first9=Eliana M.|author-link9=Eliana Lacerda|last10=Mouriño|first10=Helena|last11=Sepúlveda|first11=Nuno|date=2021|title=Herpesviruses Serology Distinguishes Different Subgroups of Patients From the United Kingdom Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Biobank|url=https:// | *2021, Herpesviruses Serology Distinguishes Different Subgroups of Patients From the United Kingdom Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Biobank<ref name="Domingues2021">{{Cite journal|last=Domingues|first=Tiago Dias|author-link=|last2=Grabowska|first2=Anna D.|author-link2=|last3=Lee|first3=Ji-Sook|author-link3=|last4=Ameijeiras-Alonso|first4=Jose|author-link4=|last5=Westermeier|first5=Francisco|author-link5=|last6=Scheibenbogen|first6=Carmen|author-link6=Carmen Scheibenbogen|last7=Cliff|first7=Jacqueline M.|author-link7=Jacqueline Cliff|last8=Nacul|first8=Luis|author-link8=Luis Nacul|last9=Lacerda|first9=Eliana M.|author-link9=Eliana Lacerda|last10=Mouriño|first10=Helena|last11=Sepúlveda|first11=Nuno|date=2021|title=Herpesviruses Serology Distinguishes Different Subgroups of Patients From the United Kingdom Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Biobank|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287507/|journal=Frontiers in Medicine|volume=8|issue=|pages=686736|doi=10.3389/fmed.2021.686736|issn=2296-858X|pmc=8287507|pmid=34291062|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287507/ (Full text)] | ||
*2021, Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS<ref name="Jakel2021">{{Cite journal|last=Jäkel|first=Bianka|author-link=|last2=Kedor|first2=Claudia|author-link2=|last3=Grabowski|first3=Patricia|author-link3=Patricia Grabowski|last4=Wittke|first4=Kirsten|author-link4=|last5=Thiel|first5=Silvia|author-link5=|last6=Scherbakov|first6=Nadja|author-link6=|last7=Doehner|first7=Wolfram|last8=Scheibenbogen|first8=Carmen|author-link8=Carmen Scheibenbogen|last9=Freitag|first9=Helma|author-link9=Helma Freitag|date=2021-04-19|title=Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS|url=https:// | *2021, Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS<ref name="Jakel2021">{{Cite journal|last=Jäkel|first=Bianka|author-link=|last2=Kedor|first2=Claudia|author-link2=|last3=Grabowski|first3=Patricia|author-link3=Patricia Grabowski|last4=Wittke|first4=Kirsten|author-link4=|last5=Thiel|first5=Silvia|author-link5=|last6=Scherbakov|first6=Nadja|author-link6=|last7=Doehner|first7=Wolfram|last8=Scheibenbogen|first8=Carmen|author-link8=Carmen Scheibenbogen|last9=Freitag|first9=Helma|author-link9=Helma Freitag|date=2021-04-19|title=Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056497/|journal=Journal of Translational Medicine|volume=19|issue=1|pages=159|doi=10.1186/s12967-021-02774-w|issn=1479-5876|pmc=8056497|pmid=33874961|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056497/ (Full text)] | ||
*2021, Delineating the Association Between Soluble CD26 and Autoantibodies Against G-Protein Coupled Receptors, Immunological and Cardiovascular Parameters Identifies Distinct Patterns in Post-Infectious vs. Non-Infection-Triggered Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref name="Szklarski2021">{{Cite journal|last=Szklarski|first=Marvin|author-link=|last2=Freitag|first2=Helma|author-link2=Helma Freitag|last3=Lorenz|first3=Sebastian|author-link3=|last4=Becker|first4=Sonya C.|author-link4=|last5=Sotzny|first5=Franziska|author-link5=Franziska Sotzny|last6=Bauer|first6=Sandra|author-link6=Sandra Bauer|last7=Hartwig|first7=Jelka|last8=Heidecke|first8=Harald|last9=Wittke|first9=Kirsten|last10=Kedor|first10=Claudia|last11=Hanitsch|first11=Leif G.|last12=Grabowski|first12=Patricia|authorlink12=Patricia Grabowski|last13=Sepúlveda|first13=Nuno|last14=Scheibenbogen|first14=Carmen|authorlink14=Carmen Scheibenbogen|date=2021|title=Delineating the Association Between Soluble CD26 and Autoantibodies Against G-Protein Coupled Receptors, Immunological and Cardiovascular Parameters Identifies Distinct Patterns in Post-Infectious vs. Non-Infection-Triggered Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|url=https:// | *2021, Delineating the Association Between Soluble CD26 and Autoantibodies Against G-Protein Coupled Receptors, Immunological and Cardiovascular Parameters Identifies Distinct Patterns in Post-Infectious vs. Non-Infection-Triggered Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref name="Szklarski2021">{{Cite journal|last=Szklarski|first=Marvin|author-link=|last2=Freitag|first2=Helma|author-link2=Helma Freitag|last3=Lorenz|first3=Sebastian|author-link3=|last4=Becker|first4=Sonya C.|author-link4=|last5=Sotzny|first5=Franziska|author-link5=Franziska Sotzny|last6=Bauer|first6=Sandra|author-link6=Sandra Bauer|last7=Hartwig|first7=Jelka|last8=Heidecke|first8=Harald|last9=Wittke|first9=Kirsten|last10=Kedor|first10=Claudia|last11=Hanitsch|first11=Leif G.|last12=Grabowski|first12=Patricia|authorlink12=Patricia Grabowski|last13=Sepúlveda|first13=Nuno|last14=Scheibenbogen|first14=Carmen|authorlink14=Carmen Scheibenbogen|date=2021|title=Delineating the Association Between Soluble CD26 and Autoantibodies Against G-Protein Coupled Receptors, Immunological and Cardiovascular Parameters Identifies Distinct Patterns in Post-Infectious vs. Non-Infection-Triggered Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056217/|journal=Frontiers in Immunology|volume=12|issue=|pages=644548|doi=10.3389/fimmu.2021.644548|issn=1664-3224|pmc=8056217|pmid=33889154|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056217/ (Full text)] | ||
==Clinic location== | ==Clinic location== | ||
| Line 85: | Line 181: | ||
==See also== | ==See also== | ||
*[[Wirth-Scheibenbogen hypothesis]] | |||
*[[Invest in ME International ME Conference]] | *[[Invest in ME International ME Conference]] | ||
*[[EUROMENE]] | *[[EUROMENE]] | ||
| Line 96: | Line 193: | ||
==References== | ==References== | ||
{{reflist}} | |||
}} | |||
[[Category:Researchers]] | [[Category:Researchers]] | ||
Revision as of 18:10, January 18, 2022
Professor Doctor Carmen Scheibenbogen is an Internal Medicine physician, ME/CFS doctor and the Professor for Immunology and Deputy Chair, Institute of Medical Immunology, at the University Hospital Charité in Berlin, Germany. Her research focuses on the role of Epstein-Barr virus (EBV), particularly the characterization of EBV specific B cell and T cell response and the enhanced antibody response against EBV peptides in myalgic encephalomyelitis (ME) versus healthy controls.[1]
Wirth-Scheibenbogen unifying hypothesis of ME/CFS[edit | edit source]
Between 2020 and 2021, with Prof. Dr Klaus Wirth, Prof. Scheibenbogen published a set of articles describing a detailed hypothesis of the pathophysiology of ME/CFS.[2][3][4]
EUROMENE[edit | edit source]
Professor Scheibenbogen is the Leader of the Biomarkers Working Group of EUROMENE, a European Union, COST Action CA15111, not-for-profit research organization committed to tackling the cause and treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.[5]
Diagnostic test[edit | edit source]
Professor Scheibenbogen helped create the CellTrend Diagnostic Test which may help identify a subset of 20-30% of all patients with ME/CFS. These patients have elevated levels of three auto-antibodies, i.e., against the b2-adrenergic receptor, against the muscarinic cholinergic receptor 3 (M3) and against the muscarinic cholinergic receptor 4 (M4).[6]
Awards[edit | edit source]
- 2016 Ramsay Award Program grant recipient, sponsored by the Solve ME/CFS Initiative for Autoimmune Signature in myalgic encephalomyelitis/chronic fatigue syndrome. This grant was shared with Madlen Löbel, Charité Universitätsmedizin Berlin.[7]
- 2017 Ramsay Award Program grant was awarded to a team comprised of Dr. Carmen Scheibenbogen and Dr. Franziska Sotzny of Charité Universitätsmedizin Berlin, sponsored by the Solve ME/CFS Initiative for researching immunometabolism of T cells and monocytes in ME/CFS.[8]
Notable studies[edit | edit source]
- 2014, Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome[9] -(Full Text)
- 2015, Frequent IgG subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome[10] -
- 2015, Polymorphism in COMT is associated with IgG3 subclass level and susceptibility to infection in patients with chronic fatigue syndrome[11] - (Full Text)
- 2016, Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome[12] - (Full Text)
- 2017, Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray[13] - (Full Text)
- 2017, The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE[14] - (Full Text)
- 2018, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – Evidence for an autoimmune disease[15] - (Full Text)
- 2018, Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME[16] - (Full Text)
- 2018, The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome[17] - (Full Text)
- 2018, Prevalence and incidence of myalgic encephalomyelitis/chronic fatigue syndrome in Europe—the Euro-epiME study from the European network EUROMENE: a protocol for a systematic review[18] - (Full text)
- 2018, Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)[19] - (Full text)
- 2020, IgG stimulated β2 adrenergic receptor activation is attenuated in patients with ME/CFS[20] - (Full text)
- 2020, Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[21] - (Full text)
- 2020, Systematic Review of the Epidemiological Burden of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Across Europe: Current Evidence and EUROMENE Research Recommendations for Epidemiology[22] - (Full text)
- 2020, Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome[23] - (Full text)
- 2020, Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated With ME/CFS With Infectious Onset[24] - (Full text)
- 2020, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Efficacy of Repeat Immunoadsorption[25] - (Full text)
- 2020, A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors[2] - (Full text)
- 2020, Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients - A validation study in plasma and cerebrospinal fluid from two Swedish cohorts[26] (Full text)
- 2021, Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)[3] - (Full text)
- 2021, The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: analysis of high-throughput epigenetic and gene expression studies[27] - (Full text)
- 2021, European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe[28] - (Full text)
- 2021, Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[29] - (Full text)
- 2021, Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept Study[30] - (Full text)
- 2021, Medical Care Situation of People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Germany[31] - (Full text)
- 2021, An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[4] - (Full text)
- 2021, S1 Guideline Post-COVID/Long-COVID[32] - (Full text, in German)
- 2021, Causal attributions and perceived stigma for myalgic encephalomyelitis/chronic fatigue syndrome[33] - (Full text)
- 2021, Herpesviruses Serology Distinguishes Different Subgroups of Patients From the United Kingdom Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Biobank[34] - (Full text)
- 2021, Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS[35] - (Full text)
- 2021, Delineating the Association Between Soluble CD26 and Autoantibodies Against G-Protein Coupled Receptors, Immunological and Cardiovascular Parameters Identifies Distinct Patterns in Post-Infectious vs. Non-Infection-Triggered Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[36] - (Full text)
Clinic location[edit | edit source]
- Charité University Medicine, Berlin, Germany
Talks and interviews[edit | edit source]
- 2021, Autoimmune ME/CFS Treatment Options - IACFS/ME Conference
- 2018, Talk "Chronic Fatigue Syndrome" for General Practitioners
- 2014, Speaker at the 9th Invest in ME International ME Conference DVD available
Online presence[edit | edit source]
See also[edit | edit source]
- Wirth-Scheibenbogen hypothesis
- Invest in ME International ME Conference
- EUROMENE
- Charité Berlin
- Solve ME/CFS Initiative
Learn more[edit | edit source]
- Carmen Schiebenbogen - Solve ME/CFS Initiative
- Carmen Schiebenbogen page 2 - Solve ME/CFS Initiative
- Curriculum Vitae for EUROMENE
References[edit | edit source]
- ↑ "Invest in ME Research - International ME Conferences and Colloquiums Home Page". investinme.org. Retrieved November 14, 2019.
- ↑ 2.0 2.1 Wirth, Klaus; Scheibenbogen, Carmen (June 1, 2020). "A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors". Autoimmunity Reviews. 19 (6): 102527. doi:10.1016/j.autrev.2020.102527. ISSN 1568-9972.
- ↑ 3.0 3.1 Wirth, Klaus J.; Scheibenbogen, Carmen (April 21, 2021). "Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)". Journal of Translational Medicine. 19 (1): 162. doi:10.1186/s12967-021-02833-2. ISSN 1479-5876. PMC 8058748. PMID 33882940.
- ↑ 4.0 4.1 Wirth, Klaus J.; Scheibenbogen, Carmen; Paul, Friedemann (November 22, 2021). "An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Journal of Translational Medicine. 19 (1): 471. doi:10.1186/s12967-021-03143-3. ISSN 1479-5876. PMC 8607226. PMID 34809664.
- ↑ "Action CA15111". COST. Retrieved November 14, 2019.
- ↑ "POTS - CFS/ME - CRPS". CellTrend Luckenwalde. Retrieved February 18, 2020.
- ↑ "2016 Ramsay Award Program Results". Solve ME/CFS Initiative. Retrieved November 14, 2019.
- ↑ "2017 Ramsay Award Program Results". Solve ME/CFS Initiative. Retrieved November 14, 2019.
- ↑ Loebel, Madlen; Strohschein, Kristin; Giannini, Carolin; Koelsch, Uwe; Bauer, Sandra; Doebis, Cornelia; Thomas, Sybill; Unterwalder, Nadine; von Baehr, Volker; Reinke, Petra; Knops, Michael; Hanitsch, Leif G.; Meisel, Christian; Volk, Hans-Dieter; Scheibenbogen, Carmen (January 15, 2014). "Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome". PLoS One. 9 (1): e85387. doi:10.1371/journal.pone.0085387.
- ↑ Guenther, Sabrina; Loebel, Madlen; Mooslechner, Agnes A; Knops, Michael; Hanitsch, Leif G; Grabowski, Patricia; Wittke, Kirsten; Meisel, Christian; Unterwalder, Nadine; Volk, Hans-Dieter; Scheibenbogen, Carmen (2015). "Frequent IgG subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome". Human Immunology. 76 (10): 729-35. doi:10.1016/j.humimm.2015.09.028.
- ↑ Loebel, Madlen; Mooslechner, Agnes Anna; Bauer, Sandra; Günther, Sabrina; Letsch, Anne; Hanitsch, Leif G; Grabowski, Patricia; Meisel, Christian; Volk, Hans-Dieter; Scheibenbogen, Carmen (2015). "Polymorphism in COMT is associated with IgG3 subclass level and susceptibility to infection in patients with chronic fatigue syndrome". Journal of Translational Medicine. 13: 264. doi:10.1186/s12967-015-0628-4. PMC 4536662. PMID 26272340.
- ↑ Loebel, M; Grabowski, P; Heidecke, H; Bauer, S; Hanitsch, LG; Wittke, K; Meisel, C; Reinke, P; Volk, H; Fluge, Ø; Mella, O; Scheibenbogen, C (2016). "Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome". Brain, behavior, and immunity. 52: 32-39. doi:10.1016/j.bbi.2015.09.013. PMID 26399744.
- ↑ Loebel, Madlen; Eckey, Maren; Sotzny, Franziska; Hahn, Elisabeth; Bauer, Sandra; Grabowski, Patricia; Zerweck, Johannes; Holenya, Pavlo; Hanitsch, Leif G.; Wittke, Kirsten; Borchmann, Peter; Rüffer, Jens-Ulrich; Hiepe, Falk; Ruprecht, Klemens; Behrends, Uta; Meindl, Carola; Volk, Hans-Dieter; Reimer, Ulf; Scheibenbogen, Carmen (2017). "Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray". PLOS ONE. 12 (6): e0179124. doi:10.1371/journal.pone.0179124.
- ↑ Scheibenbogen, Carmen; Freitag, Helma; Blanco, Julià; Capelli, Enrica; Lacerda, Eliana; Authier, Jerome; Meeus, Mira; Castro Marrero, Jesus; Nora-Krukle, Zaiga; Oltra, Elisa; Strand, Elin Bolle; Shikova, Evelina; Sekulic, Slobodan; Murovska, Modra (July 26, 2017). "The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE". Journal of Translational Medicine. 15 (1). doi:10.1186/s12967-017-1263-z. ISSN 1479-5876. PMC 5530475. PMID 28747192.
- ↑ Sotzny, Franziska; Blanco, Julià; Capelli, Enrica; Castro-Marrero, Jesús; Steiner, Sophie; Murovska, Modra; Scheibenbogen, Carmen (2018). "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – Evidence for an autoimmune disease". Autoimmunity Reviews. 17 (6): 601-609. doi:10.1016/j.autrev.2018.01.009. PMID 29635081.
- ↑ Scheibenbogen, Carmen; Loebel, Madlen; Freitag, Helma; Krueger, Anne; Bauer, Sandra; Antelmann, Michaela; Doehner, Wolfram; Scherbakov, Nadja; Heidecke, Harald; Reinke, Petra; Volk, Hans-Dieter; Grabowski, Patricia (2018). "Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME". PLoS ONE. 13 (3): e0193672. doi:10.1371/journal.pone.0193672.
- ↑ Yang, Chin-An; Bauer, Sandra; Ho, Yu-Chen; Sotzny, Franziska; Chang, Jan-Gowth; Scheibenbogen, Carmen (August 17, 2018). "The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome". Journal of Translational Medicine. 16: 231. doi:10.1186/s12967-018-1600-x. ISSN 1479-5876.
- ↑ Estévez-López, Fernando; Castro-Marrero, Jesus; Wang, Xia; Bakken, Inger Johanne; Ivanovs, Andrejs; Nacul, Luis; Sepúlveda, Nuno; Strand, Elin B.; Pheby, Derek; Alegre, José; Scheibenbogen, Carmen; Shikova, Evelina; Lorusso, Lorenzo; Capelli, Enrica; Sekulic, Slobodan; Lacerda, Eliana; Murovska, Modra (September 1, 2018). "Prevalence and incidence of myalgic encephalomyelitis/chronic fatigue syndrome in Europe—the Euro-epiME study from the European network EUROMENE: a protocol for a systematic review". BMJ Open. 8 (9): e020817. doi:10.1136/bmjopen-2017-020817. ISSN 2044-6055. PMID 30181183.
- ↑ Rasa, Santa; Nora-Krukle, Zaiga; Henning, Nina; Eliassen, Eva; Shikova, Evelina; Harrer, Thomas; Scheibenbogen, Carmen; Murovska, Modra; Prusty, Bhupesh K.; European Network on ME/CFS (EUROMENE) (October 1, 2018). "Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)". Journal of Translational Medicine. 16 (1). doi:10.1186/s12967-018-1644-y. ISSN 1479-5876. PMID 30285773.
- ↑ Hartwig, Jelka; Sotzny, Franziska; Bauer, Sandra; Heidecke, Harald; Riemekasten, Gabriela; Dragun, Duska; Meisel, Christian; Dames, Claudia; Grabowski, Patricia; Scheibenbogen, Carmen (March 1, 2020). "IgG stimulated β2 adrenergic receptor activation is attenuated in patients with ME/CFS". Brain, Behavior, & Immunity - Health. 3: 100047. doi:10.1016/j.bbih.2020.100047. ISSN 2666-3546.
- ↑ Schreiner, Philipp; Harrer, Thomas; Scheibenbogen, Carmen; Lamer, Stephanie; Schlosser, Andreas; Naviaux, Robert K.; Prusty, Bhupesh K. (April 1, 2020). "Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". ImmunoHorizons. 4 (4): 201–215. doi:10.4049/immunohorizons.2000006. ISSN 2573-7732. PMID 32327453.
- ↑ Estévez-López, Fernando; Mudie, Kathleen; Wang-Steverding, Xia; Bakken, Inger Johanne; Ivanovs, Andrejs; Castro-Marrero, Jesús; Nacul, Luis; Alegre, Jose; Zalewski, Paweł; Słomko, Joanna; Bolle Strand, Elin; Pheby, Derek; Shikova, Evelina; Lorusso, Lorenzo; Capelli, Enrica; Sekulic, Slobodan; Scheibenbogen, Carmen; Sepúlveda, Nuno; Murovska, Modra; Lacerda, Eliana (May 2020). (EUROMENE). "Systematic Review of the Epidemiological Burden of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Across Europe: Current Evidence and EUROMENE Research Recommendations for Epidemiology". Journal of Clinical Medicine. 9 (5): 1557. doi:10.3390/jcm9051557.
- ↑ Scherbakov, Nadja; Szklarski, Marvin; Hartwig, Jelka; Sotzny, Franziska; Lorenz, Sebastian; Meyer, Antje; Grabowski, Patricia; Doehner, Wolfram; Scheibenbogen, Carmen (2020). "Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome". ESC Heart Failure. 7 (3): 1064–1071. doi:10.1002/ehf2.12633. ISSN 2055-5822. PMC 7261521. PMID 32154656.
- ↑ Steiner, Sophie; Becker, Sonya C.; Hartwig, Jelka; Sotzny, Franziska; Lorenz, Sebastian; Bauer, Sandra; Löbel, Madlen; Stittrich, Anna B.; Grabowski, Patricia; Scheibenbogen, Carmen (2020). "Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated With ME/CFS With Infectious Onset". Frontiers in Immunology. 11: 578. doi:10.3389/fimmu.2020.00578. ISSN 1664-3224.
- ↑ Tölle, Markus; Freitag, Helma; Antelmann, Michaela; Hartwig, Jelka; Schuchardt, Mirjam; van der Giet, Markus; Eckardt, Kai-Uwe; Grabowski, Patricia; Scheibenbogen, Carmen (July 30, 2020). "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Efficacy of Repeat Immunoadsorption". Journal of Clinical Medicine. 9 (8): 2443. doi:10.3390/jcm9082443. ISSN 2077-0383. PMC 7465279. PMID 32751659.
- ↑ Bynke, Annie; Julin, Per; Gottfries, Carl-Gerhard; Heidecke, Harald; Scheibenbogen, Carmen; Bergquist, Jonas (August 2020). "Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients - A validation study in plasma and cerebrospinal fluid from two Swedish cohorts". Brain, Behavior, & Immunity - Health. 7: 100107. doi:10.1016/j.bbih.2020.100107. ISSN 2666-3546. PMC 8474431. PMID 34589868.
- ↑ Malato, João; Sotzny, Franziska; Bauer, Sandra; Freitag, Helma; Fonseca, André; Grabowska, Anna D; Graça, Luís; Cordeiro, Clara; Nacul, Luís; Lacerda, Eliana M; Castro-Marrero, Jesus; Scheibenbogen, Carmen; Westermeier, Francisco; Sepúlveda, Nuno (March 24, 2021). "The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: analysis of high-throughput epigenetic and gene expression studies". medRxiv. doi:10.1101/2021.03.23.21254175. PMID 33791744.
- ↑ Nacul, Luis; Authier, François Jérôme; Scheibenbogen, Carmen; Lorusso, Lorenzo; Helland, Ingrid Bergliot; Martin, Jose Alegre; Sirbu, Carmen Adella; Mengshoel, Anne Marit; Polo, Olli; Behrends, Uta; Nielsen, Henrik; Grabowski, Patricia; Sekulic, Slobodan; Sepulveda, Nuno; Estévez-López, Fernando; Zalewski, Pawel; Pheby, Derek F. H.; Castro-Marrero, Jesus; Sakkas, Giorgos K.; Capelli, Enrica; Brundsdlund, Ivan; Cullinan, John; Krumina, Angelika; Bergquist, Jonas; Murovska, Modra; Vermuelen, Ruud C. W.; Lacerda, Eliana M. (May 2021). (EUROMENE). "European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe". Medicina. 57 (5): 510. doi:10.3390/medicina57050510. PMC 8161074. PMID 34069603.
- ↑ Freitag, Helma; Szklarski, Marvin; Lorenz, Sebastian; Sotzny, Franziska; Bauer, Sandra; Philippe, Aurélie; Kedor, Claudia; Grabowski, Patricia; Lange, Tanja; Riemekasten, Gabriela; Heidecke, Harald; Scheibenbogen, Carmen (January 2021). "Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Journal of Clinical Medicine. 10 (16): 3675. doi:10.3390/jcm10163675.
- ↑ Scheibenbogen, Carmen; Sotzny, Franziska; Hartwig, Jelka; Bauer, Sandra; Freitag, Helma; Wittke, Kirsten; Doehner, Wolfram; Scherbakov, Nadja; Loebel, Madlen; Grabowski, Patricia Grabowski (January 2021). "Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept Study". Journal of Clinical Medicine. 10 (11): 2420. doi:10.3390/jcm10112420. PMC 8198960. PMID 34072494.
- ↑ Froehlich, Laura; Hattesohl, Daniel B. R.; Jason, Leonard A.; Scheibenbogen, Carmen; Behrends, Uta; Thoma, Manuel (July 2021). "Medical Care Situation of People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Germany". Medicina. 57 (7): 646. doi:10.3390/medicina57070646. PMC 8306083. PMID 34201825.
- ↑ Koczulla, Andreas Rembert; Ankermann, Tobias; Behrends, Uta; Berlit, Peter; Böing, Sebastian; Brinkmann, Folke; Franke, Christian; Glöckl, Rainer; Gogoll, Christian; Hummel, Thomas; Kronsbein, Juliane; Maibaum, Thomas; Peters, Eva M. J.; Pfeifer, Michael; Platz, Thomas; Pletz, Matthias; Pongratz, Georg; Powitz, Frank; Rabe, Klaus F.; Scheibenbogen, Carmen; Stallmach, Andreas; Stegbauer, Michael; Wagner, Hans Otto; Waller, Christiane; Wirtz, Hubert; Zeiher, Andreas; Zwick, Ralf Harun (November 2021). "S1-Leitlinie Post-COVID/Long-COVID" [S1 Guideline Post-COVID/Long-COVID]. Pneumologie (in Deutsch). 75 (11): 869–900. doi:10.1055/a-1551-9734. ISSN 0934-8387.
- ↑ Froehlich, Laura; Hattesohl, Daniel Br; Cotler, Joseph; Jason, Leonard A.; Scheibenbogen, Carmen; Behrends, Uta (July 9, 2021). "Causal attributions and perceived stigma for myalgic encephalomyelitis/chronic fatigue syndrome". Journal of Health Psychology: 13591053211027631. doi:10.1177/13591053211027631. ISSN 1461-7277. PMID 34240650.
- ↑ Domingues, Tiago Dias; Grabowska, Anna D.; Lee, Ji-Sook; Ameijeiras-Alonso, Jose; Westermeier, Francisco; Scheibenbogen, Carmen; Cliff, Jacqueline M.; Nacul, Luis; Lacerda, Eliana M.; Mouriño, Helena; Sepúlveda, Nuno (2021). "Herpesviruses Serology Distinguishes Different Subgroups of Patients From the United Kingdom Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Biobank". Frontiers in Medicine. 8: 686736. doi:10.3389/fmed.2021.686736. ISSN 2296-858X. PMC 8287507. PMID 34291062.
- ↑ Jäkel, Bianka; Kedor, Claudia; Grabowski, Patricia; Wittke, Kirsten; Thiel, Silvia; Scherbakov, Nadja; Doehner, Wolfram; Scheibenbogen, Carmen; Freitag, Helma (April 19, 2021). "Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS". Journal of Translational Medicine. 19 (1): 159. doi:10.1186/s12967-021-02774-w. ISSN 1479-5876. PMC 8056497. PMID 33874961.
- ↑ Szklarski, Marvin; Freitag, Helma; Lorenz, Sebastian; Becker, Sonya C.; Sotzny, Franziska; Bauer, Sandra; Hartwig, Jelka; Heidecke, Harald; Wittke, Kirsten; Kedor, Claudia; Hanitsch, Leif G.; Grabowski, Patricia; Sepúlveda, Nuno; Scheibenbogen, Carmen (2021). "Delineating the Association Between Soluble CD26 and Autoantibodies Against G-Protein Coupled Receptors, Immunological and Cardiovascular Parameters Identifies Distinct Patterns in Post-Infectious vs. Non-Infection-Triggered Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Frontiers in Immunology. 12: 644548. doi:10.3389/fimmu.2021.644548. ISSN 1664-3224. PMC 8056217. PMID 33889154.
